Slimming cardiac adipose tissue with liraglutide: pericardial is not epicardial fat (the LIRAFLAME substudy).

Diabetes Obes Metab

Aix Marseille Univ, APHM, INSERM, INRAE, C2VN, Department of Endocrinology, Metabolic Diseases and Nutrition, Marseille, France.

Published: March 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.14595DOI Listing

Publication Analysis

Top Keywords

slimming cardiac
4
cardiac adipose
4
adipose tissue
4
tissue liraglutide
4
liraglutide pericardial
4
pericardial epicardial
4
epicardial fat
4
fat liraflame
4
liraflame substudy
4
slimming
1

Similar Publications

Background: Primary care clinicians are encouraged to intervene opportunistically, offering weight-loss advice to people living with obesity. The BWeL trial showed patients receiving brief weight-loss advice from their general practitioner lost weight at one year follow-up. We examined the behaviour change techniques (BCTs) clinicians used to identify which BCTs are associated with this weight loss.

View Article and Find Full Text PDF

There have been rare reports of dilated cardiomyopathy from chronic use of phentermine/topiramate, although very limited data are available. Phentermine is an atypical amphetamine analog that has been contraindicated in patients with a history of cardiovascular disease. We present a case of nonischemic dilated cardiomyopathy in the setting of chronic phentermine/topiramate use, which is the most likely cause of her dilated cardiomyopathy.

View Article and Find Full Text PDF

How slimming regulatory T cells limit atherosclerosis: Mechanistic insights into T cell lipid metabolism.

Atherosclerosis

December 2022

Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich (LMU), 80336, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336, Munich, Germany; Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.

View Article and Find Full Text PDF

Background: There is evidence that commercially available behavioural weight management programmes can lead to short-term weight loss and reductions in glycaemia. Here, we aimed to provide the 5-year impact and cost-effectiveness of these interventions compared with a brief intervention.

Methods: WRAP was a non-blinded, parallel-group randomised controlled trial (RCT).

View Article and Find Full Text PDF

Prediction of disability-free survival in healthy older people.

Geroscience

June 2022

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria, 3004, Australia.

Prolonging survival in good health is a fundamental societal goal. However, the leading determinants of disability-free survival in healthy older people have not been well established. Data from ASPREE, a bi-national placebo-controlled trial of aspirin with 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!